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ABSTRACT: A 149-amino acid protein designated Cg10062 is encoded by a gene from Corynebacterium
glutamicum. The physiological function of Cg10062 is unknown, and the gene encoding this protein has
no obvious genomic context. Sequence analysis links Cg10062 to the cis-3-chloroacrylic acid dehalogenase
(cis-CaaD) family, one of the ﬁve known families of the tautomerase superfamily. The characterized
tautomerase superfamily members have two distinctive characteristics: a  -R-  structure motif and a
catalytic amino-terminal proline. Pro-1 is present in the Cg10062 amino acid sequence along with His-
28, Arg-70, Arg-73, Tyr-103, and Glu-114, all of which have been implicated as critical residues for
cis-CaaD activity. The gene for Cg10062 has been cloned and the protein overproduced, puriﬁed, and
subjected to kinetic and mechanistic characterization. Like cis-CaaD, Cg10062 functions as a hydratase:
it converts 2-oxo-3-pentynoate to acetopyruvate and processes 3-bromopropiolate to a species that inactivates
the enzyme by acylation of Pro-1. Kinetic and 1H NMR spectroscopic studies also show that Cg10062
processes both isomers of 3-chloroacrylic acid at low levels with a clear preference for the cis isomer.
Pro-1 is critical for the dehalogenase and hydratase activities because the P1A mutant no longer catalyzes
either reaction. The presence of the six key catalytic residues and the hydratase activity coupled with the
absence of an efﬁcient cis-CaaD activity and the lack of isomer speciﬁcity implicate factors beyond this
core set of residues in cis-CaaD catalysis and speciﬁcity. This work sets the stage for in-depth mechanistic
and structural studies of Cg10062, which could identify the additional features necessary for a fully active
and highly speciﬁc cis-CaaD. Such results will also shed light on how cis-CaaD emerged in the tautomerase
superfamily because Cg10062 could be characteristic of an intermediate along the evolutionary pathway
for this dehalogenase.
The degradation of the nematocide 1,3-dichloropropene
(1, Scheme 1) in Pseudomonas paVonaceae 170 is mediated
by a series of enzymes with intriguing catalytic mechanisms
and interesting evolutionary lineages (1–4). Three of these
enzymes,trans-3-chloroacrylicaciddehalogenase(CaaD)
1(5–8),
cis-3-chloroacrylic acid dehalogenase (cis-CaaD) (9–11), and
malonate semialdehyde decarboxylase (MSAD) (12, 13),
represent three different families of the tautomerase super-
family, a group of structurally homologous proteins that share
a characteristic  -R-  fold and a catalytic amino-terminal
proline (14, 15).
2 CaaD and cis-CaaD convert the corre-
sponding isomers of 3-chloroacrylate [2 and 3, respectively
(Scheme 1)] to malonate semialdehyde (4). Subsequently,
MSAD catalyzes the decarboxylation of 4 to yield acetal-
dehyde (5) and carbon dioxide (1–3).
Mechanistic and structural studies of CaaD, cis-CaaD, and
MSAD have shown that the three enzymes are strikingly
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2 5-(Carboxymethyl)-2-hydroxymuconate isomerase, a bacterial
isomerase, and macrophage migration inhibitory factor, a cytokine with
phenylpyruvate tautomerase activity, represent the other two families
in the tautomerase superfamily (14, 15).
Scheme 1
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ancestral  -R-  template (11, 13). All three enzymes
function as hydratases, converting 2-oxo-3-pentynoate (6,
Scheme 2) to acetopyruvate (7), and require Pro-1 (with a
pKa of ∼9.2) and two conserved arginines (RArg-8 and
RArg-11 in CaaD, Arg-70 and Arg-73 in cis-CaaD, and Arg-
73 and Arg-75 in MSAD) to catalyze this reaction as well
as their physiological reactions (5–13). Moreover, as a result
of this hydratase activity, the three enzymes convert the
3-halopropiolates (8 and 9, Scheme 2) to a reactive species
(e.g., an acyl halide or a ketene) that results in the acylation
of Pro-1 and enzyme inactivation (6, 9, 12). The three
enzymes have a water-activating residue (RGlu-52 in CaaD,
Glu-114 in cis-CaaD, and Asp-37 in MSAD), which has been
implicated in the hydration reactions and the respective
physiological activities (8, 11, 13). A common evolutionary
history for the three enzymes is further strengthened by a
comparison of the crystal structures, which show the core
 -R-  unit, the common overall architecture, and the
positional conservation of key catalytic residues (Pro-1 and
the arginine pair) (11, 13).
In the course of a search for other cis-CaaD family
members, a 149-amino acid protein from Corynebacterium
glutamicum, designated Cg10062, was identiﬁed. The ge-
nomic context of the cg10062 gene does not provide any
clues about the biological function of this protein in C.
glutamicum. The cg10062 gene is ﬂanked by genes encoding
putative membrane proteins that might be involved in the
transport of divalent metal ions and the diffusion of chloride
ions. Although the sequence of Cg10062 is only 34%
identical (and 53% similar) with that of cis-CaaD, six
residues are present (Pro-1, His-28, Arg-70, Arg-73, Tyr-
103, and Glu-114) that have been implicated as key players
in the cis-CaaD mechanism (9, 11). Not surprisingly, it was
found that Cg10062 catalyzes the hydration of 6 to 7 and
the conversion of 8 to a species that covalently modiﬁes Pro-
1. Kinetic analysis of Cg10062 also shows that the enzyme
has a low-level cis-CaaD activity and the ability to process
the trans isomer (i.e., 2), in contrast to the highly speciﬁc
cis-CaaD. The dehalogenase activity requires Pro-1, Arg-
70, Arg-73, and Glu-114 as mutations at these positions
render the enzyme inactive. The parallels between cis-CaaD
and Cg10062 coupled with the absence of a robust cis-CaaD
activity and isomer speciﬁcity in Cg10062 indicate that a
fully functional cis-CaaD requires catalytic features and
speciﬁcity determinants beyond the identiﬁed core set. As a
result, Cg10062 could be representative of the type of
intermediate template that gave rise to cis-CaaD.
MATERIALS AND METHODS
Materials. The sources of the chemicals, biochemicals,
buffers, solvents, components of Luria-Bertani (LB) medium,
and the enzymes and reagents used in the molecular biology
procedures are reported elsewhere (6, 9). Literature proce-
dures were used for the synthesis of 2-oxo-3-pentynoate (6)
(16) and 3-bromopropiolate (8)( 17). CaaD and cis-CaaD
were puriﬁed as previously described (6, 9) and assayed by
following the absorbance decrease at 224 nm for 2 (ε ) 4900
M-1 cm-1) and 3 (ε ) 2900 M-1 cm-1), as described
previously (6, 9). The Amicon concentrator and the YM3
and YM10 ultraﬁltration membranes were obtained from
Millipore Corp. (Billerica, MA). Sequencing-grade endopro-
teinase Glu-C (protease V-8) was purchased from F. Hoff-
mann-La Roche, Ltd. (Basel, Switzerland). Prepacked PD-
10 Sephadex G-25 columns were obtained from Biosciences
AB (Uppsala, Sweden). Oligonucleotides for DNA ampli-
ﬁcation and sequencing were synthesized by Genosys (The
Woodlands, TX).
Bacterial Strains, Plasmids, and Growth Conditions. C.
glutamicum ATCC 13032, the genomic DNA source for the
cg10062 gene,
3 was purchased from the American type
Culture Collection (Manassas, VA). Escherichia coli strain
BL21-Gold(DE3) (Stratagene, La Jolla, CA) was used in
combination with the T7 expression system (pET3b vector)
for expression of wild-type Cg10062 and the four mutants
(P1A, R70A, R73A, and E114Q). C. glutamicum cells were
grown at 37 °C in nutrient broth medium. E. coli cells were
grown at either 30 °C (for protein expression) or 37 °C (for
plasmid preparation) in LB medium supplemented with
ampicillin (Ap, 100 µg/mL), as indicated.
General Methods. General procedures for cloning and
DNA manipulation were performed as described previously
(18). The PCR was carried out in a Perkin-Elmer model 480
DNA thermocycler obtained from Perkin-Elmer Inc. (Welle-
sley, MA). DNA sequencing was performed by the DNA
Core Facility of the Institute for Cellular and Molecular
Biology at The University of Texas. The procedures for
protein analysis using sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) on 15% gels (19) and
protein quantiﬁcation are reported elsewhere (20). The native
molecular mass of wild-type Cg10062 was determined by
gel ﬁltration on the Superose 12 column. Kinetic data were
obtained on a Hewlett-Packard 8452A diode array spectro-
photometer or an Agilent 8453 UV-visible spectrophotom-
eter. The kinetic data were ﬁtted by nonlinear regression data
analysis using Graﬁt (Erithacus Software Ltd., Horley, U.K.)
obtained from Sigma Chemical Co. Nuclear magnetic
resonance (NMR) spectra were recorded in 100% H2Oo na
Varian Unity INOVA-500 spectrometer as reported previ-
ously (6).
Construction of the Cg10062 Expression Vector. To
remove an internal BamHI restriction site, the cg10062
gene was generated by overlap extension PCR (21). The
forward primer (5′-ATACATATGCCTACTTATACT-
TGT-3′) is designated primer F1 and contains an NdeI
restriction site (in bold) followed by 15 bases correspond-
ing to the coding sequence of the cg10062 gene. The
reverse primer (5′-CATGGATCCCTATTCTGACGATCC-
3′) is designated primer R1 and contains a BamHI
restriction site (in bold) followed by 15 bases correspond-
ing to the complementary sequence of the cg10062 gene.
The internal PCR primers were oligonucleotides 5′-
3 The Cg10062 protein and gene identiﬁcation numbers are
NP_599314.1 and 19551312, respectively.
Scheme 2
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GATTCCAAGAATCAG-3′, where the silent mutation
resulting in deletion of the internal BamHI site is indicated
in bold. Total genomic DNA from C. glutamicum ATCC
13032 was isolated by a phenol extraction procedure
described previously (22). Ampliﬁcation mixtures con-
tained the appropriate synthetic primers, deoxynucleotide
triphosphates, genomic DNA, and PCR reagents supplied
in the Expand High Fidelity PCR system. The resulting
PCR product and the pET3b vector were digested with
NdeI and BamHI restriction enzymes, puriﬁed, and ligated
using T4 DNA ligase. An aliquot of the ligation mixture
was transformed into competent E. coli BL21-Gold(DE3)
cells. Transformants were selected at 37 °C on LB/Ap
plates. Plasmid DNA was isolated from several randomly
selected colonies and analyzed by restriction analysis
for the presence of the insert. The cloned cg10062 gene
was sequenced to verify that no other mutations had
been introduced during the ampliﬁcation of the gene. The
newlyconstructedexpressionvectorwasnamedpET(cg10062).
Construction of the Cg10062 Mutants and Expression and
Puriﬁcation of Wild-Type and Mutant Proteins. The experi-
mental procedures used for the construction of the P1A,
R70A, R73A, and E114Q Cg10062 mutants are provided
in the Supporting Information. In addition, protocols used
for the production and puriﬁcation of wild-type Cg10062
and the four mutant proteins are reported in the Supporting
Information. Finally, the mass spectral analysis of the four
mutant proteins can be found in the Supporting Informa-
tion.
Mass Spectrometric Characterization of Cg10062 and
Cg10062 InactiVated by 8. The masses of Cg10062 and
Cg10062 inactivated by 8 were determined using an LCQ
electrospray ion trap mass spectrometer (Thermo, San
Jose, CA), housed in the Analytical Instrumentation
Facility Core in the College of Pharmacy at The University
of Texas. The protein samples were prepared as described
previously (6). The observed monomer mass for Cg10062
was 17092 Da (calcd 17096 Da). The mass for the
modiﬁed Cg10062 sample is reported below.
1H NMR Spectroscopic Product Analysis of the Reaction
of Cg10062 with 2-Oxo-3-pentynoate (6). The product of
the Cg10062-catalyzed hydration of 2-oxo-3-pentynoate
(6) was identiﬁed as acetopyruvate (7)b y1H NMR
spectroscopy using a procedure described elsewhere with
the following modiﬁcations (6, 9). Six individual reaction
mixtures consisted of H2O (800 µL) and an aliquot of 6
(100 µL) from a stock solution. The stock solution of 6
(4 mg, 36 mmol) was created in 100 mM Na2HPO4 buffer
(pH 9.2, 0.6 mL), and the pH of the solution was adjusted
to 7.6 with aliquots of an aqueous 1 M NaOH solution.
The stock solution was used immediately after preparation.
A quantity of Cg10062 (100 µL of a 3.2 mg/mL solution)
was added to each reaction mixture. After 18 h at 4 °C,
the reaction mixtures were combined and the enzyme was
removed as described previously (6, 9). The efﬂuent was
concentrated to ∼0.6 mL in vacuo and placed in a NMR
tube along with DMSO-d6 (30 µL). The 1H NMR spectrum
shows the presence of signals corresponding to 6, 7, the
hydrate of 7, and the enol isomer of 7 (23). Under these
conditions, inactivation of Cg10062 was not observed.
1H NMR Spectroscopic Detection of 4 in the Cg10062-
Catalyzed Dehalogenation of 3. A series of 1H NMR
spectra monitoring the Cg10062-catalyzed transformation
of cis-3-chloroacrylate (3) was recorded as follows. An
amount of 3 (4 mg, 0.04 mmol) dissolved in DMSO-d6
(30 µL) was added to 100 mM Na2HPO4 buffer (0.6 mL,
pH ∼9) and placed in a NMR tube. The pH of the reaction
mixture containing 3 was adjusted to 9.0 using small
aliquots of an aqueous 1 M NaOH solution. Subsequently,
an aliquot of Cg10062 (50 µL of a 3.2 mg/mL solution
of Cg10062) from a solution created in 20 mM Na2HPO4
buffer (pH 7.3) was added to the reaction mixture. The
ﬁrst 1H NMR spectrum was recorded 5 min after the
addition of enzyme and every 3 min thereafter for a total
reaction time of 32 min. The ﬁnal pH of the reaction
mixture was 7.3. The 1H NMR spectra showed signals
for cis-3-chloroacrylate (3), malonate semialdehyde (4),
its hydrate, acetaldehyde (5), and its hydrate (6). Acetal-
dehyde presumably results from the nonenzymatic decar-
boxylation of 4 but could also be due to a promiscuous
MSAD activity of Cg10062. The mixture contained ∼67%
3, as assessed by integration of the signals.
1H NMR Spectroscopic Analysis of Incubation Mixtures
Containing 2 and Cg10062 or cis-CaaD. In separate
experiments, Cg10062 or cis-CaaD was incubated with
the trans isomer of 3-chloroacrylate (i.e., 2), and the
reactions were followed by 1H NMR spectroscopy (6).
An amount of 2 (4 mg, ∼0.04 mmol) dissolved in DMSO-
d6 (30 µL) was added to 100 mM Na2HPO4 buffer (0.6
mL, pH ∼9) and placed in a NMR tube. The pH of the
reaction mixtures was adjusted to 9.5. Subsequently,
Cg10062 [100 µL of a 22 mg/mL solution in 20 mM
Na2HPO4 buffer (pH 8.0)] or cis-CaaD [40 µL of a 31.1
mg/mL solution in 20 mM Na2HPO4 buffer (pH 8.0)] was
added to the reaction mixture. Both reaction mixtures were
examined by 1H NMR spectroscopy after an initial
incubation period (46 h for Cg10062 and 41 h for cis-
CaaD) and a lengthy incubation period (6 weeks). To
minimize photoisomerization, the NMR tubes containing
the reaction mixtures were stored in the dark except when
they were analyzed by NMR spectroscopy. After 6 weeks,
the mixture of Cg10062 and 2 exhibited signals corre-
sponding to 2 (∼6%), 4 (∼6%), the hydrate of 4 (∼16%),
5 (∼30%), and the hydrate of 5 (∼41%) (6). The
approximate quantities were determined by integration.
The 1H NMR spectra for the mixture containing cis-CaaD
and 2 exhibited only signals corresponding to 2.
Kinetic Assays. All the kinetic assays were performed
at 23 °C and pH ∼9.0. Previous work has shown that the
highest cis-CaaD activity is observed at this pH (9, 10).
The assays used for the colorimetric determination of the
dehalogenation of 2 and 3 and to follow the hydration of
6 are based on protocols reported elsewhere (5, 6). The
modiﬁcations to these assays are provided in the Sup-
porting Information. In a coupled assay, the dehalogena-
tion of 2 by CaaD, 3 by cis-CaaD, and 2 or 3 by Cg10062
was monitored by following the production of NADH from
NAD+ at 340 nm (ε ) 6220 M-1 cm-1). The assay
mixtures (total volume of 1 mL) were created in 20 mM
Na2HPO4 buffer (pH 9.0) and contained dithiothreitol (0.1
mM), NAD+ [350 µM, 10 µL of a 26.5 mg/mL stock
solution in 100 mM Na2HPO4 buffer (pH 9.0)], aldehyde
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solution in 100 mM Na2HPO4 buffer (pH 9.0)], FG41
MSAD
4 [∼0.1 mg, 10 µL of a 9.3 mg/mL stock solution
in 10 mM Na2HPO4 buffer (pH 8.0)], 2 or 3 [10-150
m Mf r o ma1Mstock solution made up in 100 mM
Na2HPO4 buffer (pH 9.0)], and CaaD (30 nM), cis-CaaD
(39 nM), or Cg10062 (0.27 µM using 2 and 0.07 µM using
3). The assays were initiated by the addition of 2 or 3
and followed for 5 min.
1H NMR Spectroscopic Assay for CaaD and cis-CaaD
ActiVities of the P1A, R70A, R73A, and E114Q Cg10062
Mutants. An amount of 2 or 3 (4 mg, ∼0.04 mmol) dissolved
in DMSO-d6 (30 µL) was added to 100 mM Na2HPO4 buffer
(0.6 mL, pH ∼9) and placed in a NMR tube (6). The pH of
the reaction mixture was adjusted to 9.5. Subsequently,
enzyme [∼1.0 mg made up in 20 mM Na2HPO4 buffer (pH
8.0)] was added to the reaction mixture. The eight reaction
mixtures were examined by 1H NMR spectroscopy after a
17-18 h incubation period, and the product amounts were
estimated by integration of the signals corresponding to 2
(or 3), 4, 5, and the corresponding hydrates (6), if present.
The 1H NMR signals for these species are reported elsewhere
(6). The pH after the inubation period ranged between 8.1
and 8.5 for all samples except for the sample containing
E114Q and 3, which had a ﬁnal pH of 7.3.
IrreVersible InactiVation of Cg10062 by 8, Mass Spectral
Analysis, and Peptide Mapping. The enzyme (20 µM based
on the molecular mass of the native enzyme) was incubated
with a large excess of 8 (0.5 mM) in 0.5 mL of 20 mM
NaH2PO4 buffer (pH 7.3) for 28 h at 4 °C( 6). In a separate
control experiment, the same quantity of enzyme was
incubated without inhibitor under otherwise identical condi-
tions. Subsequently, the two samples were loaded onto
individual PD-10 Sephadex G-25 gel ﬁltration columns,
which had previously been equilibrated with 100 mM
(NH4)HCO3 buffer (pH 8.0). The protein was eluted with
the same buffer by gravity ﬂow. Fractions (0.5 mL) were
analyzed for the presence of protein by UV absorbance at
214 nm. The puriﬁed enzymes were assayed for residual cis-
CaaD activity using the colorimetric assay for dehalogenation
(5). The sample treated with 8 had no activity, while the
control sample retained full activity. Subsequently, the
samples were analyzed by electrospray ionization mass
spectrometry (ESI-MS) and used in the following peptide
mapping experiments.
For the peptide mapping experiments, a quantity (∼25 µg)
of unmodiﬁed Cg10062 and Cg10062 inactivated by 8 was
dried under vacuum (6). The individual protein pellets from
the two samples were dissolved in 10 µL of 10 M guanidine
HCl and incubated for2ha t3 7°C. Subsequently, the protein
samples were diluted 10-fold with 100 mM (NH4)HCO3
buffer (pH 8.0) and incubated for 48 h at 37 °C with protease
V-8 (2.5 µL of a 10 mg/mL stock solution created in
water) (24, 25). The protease V-8-treated samples were made
up and analyzed on the delayed extraction Voyager-DE PRO
matrix-assisted laser desorption ionization time-of-ﬂight
(MALDI-TOF) instrument (PerSeptive Biosystems, Framing-
ham, MA) as previously described (6). Selected ions of the
samples were also subjected to MALDI-PSD analysis using
the protocol described previously to identify the covalently
modiﬁed residue (26).
RESULTS
Expression, Puriﬁcation, and Characterization of Cg10062.
The cg10062 gene was ampliﬁed from genomic DNA of C.
glutamicum and fused into the start codon of expression
vector pET3b, resulting in the pET(cg10062) construct. The
cg10062 gene in pET(cg10062) is under the control of a T7
promoter, and the enzyme was produced constitutively in a
soluble and active form in E. coli BL21(DE3). The recom-
binant enzyme was puriﬁed by two methods. For all
experiments except those involving low-level activities, the
cell lysate was routinely processed through two HPLC
columns (anion exchange and hydrophobic interaction),
followed by a gel ﬁltration step (if necessary). For the
identiﬁcation and quantiﬁcation of low-level activities, the
cell lysate was processed similarly but passed through hand-
packed disposable columns. Typically, both procedures yield
∼50 mg of homogeneous protein per liter of culture. The
subunit and native molecular masses were determined to be
17092 ( 2D aa n d∼50 kDa, respectively. A comparison of
these values to the calculated subunit mass (17227 Da)
indicates that the initiating methionine is removed during
posttranslational processing, resulting in a protein with an
N-terminal proline, and suggests that the native enzyme is a
homotrimeric protein.
Hydration of 2-Oxo-3-pentynoate (6) by Cg10062. It has
previously been determined that CaaD and cis-CaaD function
as hydratases and convert 2-oxo-3-pentynoate (6, Scheme
2) to acetopyruvate (7)( 6, 9). These observations prompted
us to examine whether Cg10062 catalyzes the hydration of
6. The results show that Cg10062 converts 6 to 7 and that
the catalytic efﬁciency is slightly higher than that observed
for cis-CaaD (9). The identity of 7 was conﬁrmed by 1H
NMR spectroscopy. The 1H NMR spectrum exhibited signals
consistent with the structure of 7, as well as two additional
species, the hydrate of 7 and the enol of 7 (6). We have
previously shown that 6 is stable for several hours in solution
and does not decompose to 7 (6). Cg10062 is inactivated by
high concentrations of 6 (>60 mM) with no detectable
conversion of 6 to 7.
The kinetic parameters for the conversion of 6 to 7 by
Cg10062 and those previously measured for cis-CaaD and
CaaD are summarized in Table 1. A comparison of these
parameters indicates that the kcat value for Cg10062 is 47-
fold higher than that measured for cis-CaaD while the Km
4 FG41 MSAD is a MSAD homologue found in coryneform
bacterium strain FG41. Although FG41 MSAD and MSAD from P.
paVonaceae 170 are only 37% identical in sequence, they have
comparable decarboxylase activities, but the FG41 MSAD lacks a
hydratase activity (H. Serrano, G. J. Poelarends, W. H. Johnson, Jr.,
and C. P. Whitman, 2008, unpublished results).
Table 1: Kinetic Parameters for the Cg10062-, cis-CaaD-, and
CaaD-Catalyzed Conversion of 2-Oxo-3-pentynoate (6) to Acetopyruvate
(7)
a
enzyme kcat (s-1) Km (µM) kcat/Km (M-1 s-1)
Cg10062 0.33 ( 0.03 6200 ( 750 0.05 × 103
cis-CaaD
b 0.007 ( 0.001 620 ( 60 0.01 × 103
CaaD
c 0.7 ( 0.02 110 ( 4 6.4 × 103
a The steady-state kinetic parameters were determined in 20 mM
Na2HPO4 buffer (pH 9.0) at 23 °C. Errors are standard deviations.
b These parameters were obtained from ref 9.
c These parameters were
obtained from ref 6.
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Km value. In contrast, the kcat value for CaaD is ∼2-fold
higher than that measured for Cg10062 while the Km value
is ∼56-fold lower. As a result, the kcat/Km value for CaaD is
∼130-fold higher than that observed for Cg10062.
Dehalogenation of 2 and 3 by Cg10062. The level of
sequence identity with cis-CaaD and the hydratase activity
suggested that Cg10062 might function as a cis-CaaD.
However, the low cis-CaaD activity (and CaaD activity) of
Cg10062 precluded the use of a previously described assay,
which follows the decrease in substrate absorbance at 224
nm (9). The absorbance of the large amount of substrate and
protein required to produce a detectable reaction rate does
not permit accurate measurements at 224 nm. Hence, a
coupled assay was developed that follows the formation of
NADH from NAD+. In this assay, dehalogenation of 2 or 3
produces 4, which is decarboxylated by MSAD to afford
acetaldehyde (5). The large excess of aldehyde dehydroge-
nase converts 5 to acetate, and the oxidation of 5 is coupled
to the reduction of NAD+. The kinetic parameters for CaaD
and cis-CaaD with their respective isomers were determined
by this coupled assay and compared with those measured
by the 224 nm assay and a previously described colorimetric
assay (5) (Table 2). For CaaD, the kinetic parameters are
comparable (<2-fold difference). For cis-CaaD, the Km and
kcat values determined using the coupled assay are higher
(∼4.5- and ∼2.5-fold, respectively), but the overall kcat/Km
values are comparable. The higher values may be a more
accurate reﬂection of the cis-CaaD activity because the
absorbance at 224 nm is not the λmax for 3 but rather
corresponds to a shoulder. The colorimetric assay, which
monitors halide release, is not accurate at substrate concen-
trations of <400 µM, so Km values cannot be measured (5).
Using the coupled assay and the colorimetric assay, the
dehalogenase activity for Cg10062 with 2 and 3 was
determined (Table 3). A comparison of the parameters
measured in the coupled assay shows that the Km values are
signiﬁcantly higher than those measured for CaaD and cis-
CaaD (∼2800- and ∼125-fold, respectively). The kcat value
for Cg10062 using the trans isomer is ∼32-fold lower than
that determined for CaaD. The kcat value for Cg10062 using
the cis isomer is comparable to that of cis-CaaD. Overall,
the kcat/Km values show that Cg10062 is much less efﬁcient
in processing the trans isomer than CaaD is (∼8.5 × 104-
fold). Cg10062 clearly prefers the cis isomer, but does not
process it as efﬁciently as cis-CaaD (∼160-fold). The values
measured in the colorimetric assay are in accord with these
observations. However, in contrast to CaaD and cis-CaaD,
Cg10062 processes both isomers.
Mixtures containing Cg10062 and either the cis or trans
isomer were monitored by 1H NMR spectroscopy to verify
that the product of these reactions is 4, which was previously
established for the cis-CaaD- and CaaD-catalyzed reactions
(6, 9). Indeed, the enzymatic conversion of 2 or 3 yields 4,
as indicated by a doublet at 3.20 ppm and a triplet at 9.50
ppm (data not shown), which correspond to the protons at
C-2 and C-3, respectively (6). In addition, signals corre-
sponding to the hydrate of 4 are present. Hence, 4 is the
product of the Cg10062-catalyzed conversion of 2 and 3.
For the reaction of Cg10062 and 3, the reaction was ∼33%
complete after 32 min.
By NMR spectroscopy, it took a signiﬁcant period of time
(∼6 weeks) to detect product using Cg10062 and the trans
isomer (i.e., 2). The lengthy incubation period prompted us
to examine (by NMR spectroscopy) whether cis-CaaD
processed the trans isomer after a comparable incubation
period. After 6 weeks, there was no detectable product
formation in the incubation mixture containing cis-CaaD and
2, whereas the mixture containing Cg10062 and 2 was ∼95%
complete.
Construction and Kinetic and 1H NMR Analysis of the P1A,
R70A, R73A, and E114Q Cg10062 Mutants. Four residues
present in Cg10062 (Pro-1, Arg-70, Arg-73, and Glu-114) have
counterparts in cis-CaaD and CaaD that have been identiﬁed
as critical active site residues. Hence, four site-directed mutants
were constructed (P1A, R70A, R73A, and E114Q Cg10062)
and puriﬁed so the importance of these residues to the
dehalogenation of 2 and 3 could be examined. The mutants
have no detectable dehalogenase activity using the colorimetric
assay (after an overnight incubation) and no detectable hydratase
activity (using 6). These results are not surprising in view of
the low activities of the wild-type enzyme. Nonetheless, the
results suggest that all four residues are required for the
dehalogenation of 2 and 3 and the hydration of 6.
The dehalogenase activities of the four mutants were also
assessed by 1H NMR spectroscopy after a 17-18 h incuba-
tion period. Using the cis isomer (3), the E114Q-catalyzed
reaction was 100% complete and the P1A-catalyzed reaction
showed a trace amount of product (4 and the hydrate), but
not a sufﬁcient amount for quantiﬁcation. Mixtures contain-
ing the R70A and R73A Cg10062 mutants showed no
product. The observations parallel those observed for cis-
CaaD using 3 and suggest that Pro-1, Arg-70, and Arg-73
are more critical for the cis-CaaD activity of Cg10062 than
Glu-114. Using the trans isomer (2), the E114Q-catalyzed
reaction results in 4% product. Mixtures containing the P1A,
Table 2: Kinetic Parameters for CaaD- and cis-CaaD-Catalyzed
Dehalogenation of 2 and 3
enzyme substrate assay Km (µM) kcat (s-1)
kcat/Km
(M-1 s-1)
CaaD 2 224 nm
a 49 ( 5 1.9 ( 0.1 3.9 × 104
CaaD 2 coupled
b 28 ( 3 1.9 ( 0.6 6.8 × 104
CaaD 2 colorimetric
c ND
d 1.5 ND
d
cis-CaaD 3 224 nm
a 34 ( 8 1.8 ( 0.2 5.3 × 104
cis-CaaD 3 coupled
b 152 ( 20 4.6 ( 0.3 3.0 × 104
cis-CaaD 3 colorimetric
c ND
d 1.0 ND
d
a The kinetic parameters were measured in 20 mM Na2HPO4 buffer
(pH 9.0) at 22 °C following the decrease in absorbance at 224 nm.
Errors are standard deviations.
b The kinetic parameters were measured
in 20 mM Na2HPO4 buffer (pH 9.0) at 22 °C. Errors are standard
deviations.
c The kinetic parameters were measured in 50 mM Tris-SO4
buffer (pH 9.0) at 22 °C. Errors are standard deviations.
d Not
determined.
Table 3: Kinetic Parameters for the Cg10062-Catalyzed Dehalogenation
of 2 and 3
enzyme substrate assay Km (mM) kcat (s-1)
kcat/Km
(M-1 s-1)
Cg10062 2 coupled
a 78 ( 36 0.06 ( 0.01 0.8
Cg10062 2 colorimetric
b 54 ( 40 0.002 ( 0.001 0.04
Cg10062 3 coupled
a 19 ( 1 3.5 ( 1.1 184
Cg10062 3 colorimetric
b 156 ( 42 1.6 ( 0.3 10
a The kinetic parameters were measured in 20 mM Na2HPO4 buffer
(pH 9.0) at 22 °C. Errors are standard deviations.
b The kinetic
parameters were measured in 50 mM Tris-SO4 buffer (pH 9.0) at 22 °C.
Errors are standard deviations.
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Again, Pro-1, Arg-70, and Arg-73 are more critical for the
CaaD activity of Cg10062 than Glu-114.
IrreVersible Inhibition of Cg10062 by 8. It is well
established that 3-bromopropiolate (8, Scheme 2) irreversibly
inhibits CaaD and cis-CaaD (6, 9). The inhibition results from
the covalent modiﬁcation of the catalytic Pro-1 by a species
formed as a result of the enzyme-catalyzed hydration of 8
(Scheme 4) (6, 8, 9). In view of the hydratase activity of
Cg10062, we anticipated that 8 would also lead to irreversible
inhibition of Cg10062. After a 28 h incubation period (at 4
°C) with 8, Cg10062 was irreversibly inhibited. Gel ﬁltration
chromatography did not result in recovery of enzyme activity,
indicating that a covalent bond has formed between Cg10062
and a species (either 15 or 16 in Scheme 4) derived from
the enzymatic hydration of 8.
ESI-MS Analysis of the InactiVated Cg10062. To identify
the species resulting in the covalent modiﬁcation of Cg10062,
the enzyme was incubated with 8, and the inactivated protein
was isolated and analyzed by ESI-MS. A control sample
containing only Cg10062 was processed and analyzed
similarly. Mass spectral analysis of the Cg10062 control
sample showed one major peak corresponding to a mass of
17092 ( 2 Da. Mass spectral analysis of Cg10062 incubated
with 8 showed two major peaks corresponding to masses of
17134 ( 2 and 17178 ( 2 Da. The mass of the latter species
(i.e., 17178 Da) is in agreement with that expected for the
enzyme modiﬁed with a 3-oxopropanoate group (+86 Da),
the adduct resulting from the enzyme-catalyzed hydration
of 8 (17 in Scheme 4). This observation is consistent with
the mass spectral analysis of CaaD and cis-CaaD inactivated
by 8, which are also modiﬁed by a molecule with a mass of
86 Da (6, 8, 9). The species with a mass of 17134 Da,
however, reveals the addition of a covalent adduct having a
mass of 42 Da. This adduct (18 in Scheme 4) most likely
represents the same label, but in this case, the 3-oxopro-
panoate moiety, a  -keto acid, has lost CO2.
5
Identiﬁcation of the Modiﬁed Residue by Mass Spectrom-
etry. The site of the modiﬁcation was ﬁrst localized to a
peptide fragment of Cg10062 by digesting the modiﬁed and
unmodiﬁed Cg10062 samples with protease V-8 and analyz-
ing the resulting peptide mixtures by MALDI-MS. Under
the incubation mixture conditions, protease V-8 cleaves
peptide bonds preferentially at the carboxylate side of
glutamate residues (24, 25). There are 23 glutamate residues
in Cg10062 so that a complete digestion will result in 24
fragments or amino acid residues. This analysis assumes that
there is no hydrolytic cleavage of the peptide bond at the
carboxylate side of the two aspartate residues. A comparison
of the peaks for the modiﬁed and unmodiﬁed Cg10062
samples revealed a single modiﬁcation by a species having
a mass of 42 Da on the peptide fragment from Pro-1 to Glu-
15.
5 Analysis of the remaining peaks showed no modiﬁcation
of other fragments (data not shown).
To determine the single covalently modiﬁed residue,
selected peaks observed in the protease V-8-digested control
sample and in the protease V-8-digested sample treated with
8 were subjected to MALDI-PSD fragmentation analysis
(Table 4) (26). The PSD spectrum of the ion corresponding
to the unlabeled peptide (Pro-1 to Glu-15) displays the
characteristic immonium ion at m/z 70.1 (resulting from Pro-
1) and N-terminal sequence-speciﬁc fragment ion b2, which
results from the dipeptide, Pro-1-Thr-2 [Cg10062 peptide
(Table 4)]. MALDI-PSD fragmentation analysis of the ion
corresponding to the peptide modiﬁed by a species derived
from 8 shows an increase in mass of 42 Da for the b2
fragment ion [covalently modiﬁed Cg10062 peptide (Table
4)]. Thus, only Pro-1 and Thr-2 remain as potential targets
of alkylation. Further evidence implicating Pro-1 as the site
of modiﬁcation was provided by the presence of the
immonium and b1 fragment ions in the PSD spectrum of the
modiﬁed peptide, with mass values consistent with the
covalent attachment of a single species with a mass of 42
Da to the Pro-1 residue (Table 4). While the b1 ion,
5 ESI-MS analysis of Cg10062 treated with 8 shows two species
with molecular masses of 42 and 86 Da. However, the MALDI-MS
spectrum shows only one species with a molecular mass of 42 Da. We
have previously attributed this observation to the matrix-induced loss
of the CO2 group from the 3-oxopropanoate adduct, a  -keto
acid (6, 8, 9).
Scheme 3
Scheme 4 Table 4: PSD Fragment Ions of the Peptide Fragment from Pro-1 to
Glu-15 from Cg10062 and Cg10062 Treated with 8
observed or calculated PSD
fragment ion mass
a
sample P-immonium ion b1 b2
calculated 70.1 98.1 199.2
Cg10062 peptide 70.1 ND
b 199.0
covalently modiﬁed peptide 111.9 139.7 240.8
a The immonium ion has lost the CO group of the peptide amide,
while the b ion retains this group.
b Not detected.
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observed in PSD spectra (26), it is apparently stabilized by
its modiﬁcation with the adduct, accounting for the presence
of this ion in the spectrum of the sample treated with 8.
DISCUSSION
Sequence analysis, crystallographic observations, and the
results of mechanistic, mutagenesis, and inhibition studies
have established working hypotheses for the CaaD and cis-
CaaD mechanisms (Scheme 3) (5–11). For CaaD, RGlu-52
activates a water molecule for attack at C-3 and RArg-8 and
RArg-11 bind and interact with the C-1 carboxylate group
(8). This interaction likely draws electron density away from
C-3, thereby creating a partial positive charge and enhancing
the electrophilicity of C-3. The proposed enediolate inter-
mediate, 10, can rearrange with protonation at C-2 (from
 Pro-1) to generate the unstable halohydrin species 11
(Scheme 3A). Subsequent chemical or enzymatic decay
produces 4. Alternatively, the enediolate can rearrange to
eliminate the halide and form an enol intermediate (12,
Scheme 3B). Subsequent formation of the carbonyl group
and protonation at C-2 (by  Pro-1) afford 4. Recent work
implicates the enol intermediate in Scheme 3B, but the
scenario shown in Scheme 3A cannot be ruled out (27). The
proposed mechanism for cis-CaaD is largely the same except
two additional residues, His-28 and Tyr-103, are involved
(11). It is proposed that His-28 assists Arg-70 and Arg-73
in the binding and activation of substrate and Tyr-103 assists
Glu-114 in the activation of the water molecule for attack at
C-3. Pro-1 again provides the proton at C-2.
A comparison of the structure of CaaD inactivated by 8
with those of cis-CaaD (both native and one inactivated by
an epoxide) suggests that the different active site shapes and
substrate orientations might govern isomer speciﬁcity (11).
The active site of CaaD is elongated, and the interaction of
the substrate’s carboxylate group with the two arginine
residues projects the substrate into the enzyme. In contrast,
the active site of cis-CaaD is more U-shaped, and His-28
(along with Arg-70 and Arg-73) directs the substrate toward
the surface of the enzyme. Modeling studies show that the
3-chloro group of the cis isomer could bind in a pocket
formed by Thr-34, Leu-38, Leu-119, and Arg-70 (11). These
same studies indicate that Tyr-103 would effectively block
the binding of the 3-chloro group of a trans substrate.
The high degree of sequence similarity between Cg10062
and cis-CaaD (∼53%) coupled with the conservation of the
six key active site residues suggested that Cg10062 would
behave like cis-CaaD and function as an isomer-speciﬁc
dehalogenase. Studies with 2-oxo-3-pentynoate (6, Scheme
2) support this view. Cg10062 catalyzes the hydration of 6
to produce acetopyruvate (7) with a catalytic efﬁciency
somewhat better than that observed for the cis-CaaD reaction
(as assessed by kcat/Km values) (9). However, both reactions
are signiﬁcantly less efﬁcient than CaaD, which is rational-
ized by the fact that the elongated active site of CaaD can
more easily accommodate the linear acetylene molecule (5, 9).
The observation that Cg10062 processes 6 instead of being
inactivated by 6 implies that Pro-1 has a pKa comparable to
that determined for CaaD and cis-CaaD (∼9.2) (7, 10). A
growing body of evidence suggests that the reaction of 6
with tautomerase superfamily members reﬂects the predomi-
nant ionization state of Pro-1 (neutral vs cationic) (28, 29).
For example, the incubation of CaaD, cis-CaaD, and MSAD
with 6 results in the conversion of 6 to 7 due to the cationic
Pro-1 and these enzymes’ ability to carry out a hydration
reaction (5, 9, 28, 29). In contrast, 4-oxalocrotonate tau-
tomerase (4-OT) and a 4-OT homologue from Bacillus
subtilis designated YwhB are irreversibly inactivated by 6
because Pro-1 is neutral in these enzymes (at physiological
pH), allowing them to function as bases with pKa values of
∼6.4
6 (16, 30).
The results of the studies with 8 also show that Cg10062
and cis-CaaD function similarly. The 3-halopropiolates (i.e.,
8 and 9, Scheme 2) have been shown previously to be
irreversible inhibitors of CaaD, cis-CaaD, and MSAD
(5, 9, 12). In all three cases, Pro-1 is modiﬁed by a
3-oxopropanoate moiety (17 in Scheme 4), and two possible
mechanisms for generating this adduct have been proposed
(5, 8, 9, 12, 13). For CaaD, cis-CaaD, and MSAD, inactiva-
tion proceeds through the enzyme-mediated attack of water
at C-3 of 8 (Scheme 4). The resulting allenic species 13
rearranges to 14, which can then decompose by two routes.
In one route, direct expulsion of the bromide produces a
ketene (i.e., 15) which can modify Pro-1. In a second route,
tautomerization of 14 (and protonation at C-2) yields acyl
bromide 16. Subsequent acylation of Pro-1 by 16 inactivates
the enzyme. It is postulated that Pro-1 becomes nucleophilic
as a consequence of the initial hydration of 8 by the enzyme.
Clearly, Cg10062 functions as a hydratase using 6 and 8,
and its behavior with these compounds largely mirrors that
of cis-CaaD. However, in spite of these similarities, Cg10062
is a poor cis-CaaD: it has a much lower catalytic efﬁciency,
and it does not display absolute speciﬁcity for the cis isomer.
The lower catalytic efﬁciency stems from the much higher
Km value, which suggests suboptimal binding of the cis
isomer in the active site of Cg10062. Unlike that of cis-
CaaD, the active site of Cg10062 can also accommodate and
process the trans isomer, albeit poorly. The lower catalytic
efﬁciency of this reaction (in comparison to the kcat/Km of
the CaaD-catalyzed reaction) results from a higher Km value
combined with a lower kcat. The lower afﬁnity for the
substrate could again be due to suboptimal alignment,
whereas the lower kcat value could be due to an effect on the
reaction chemistry, product release, or both. The mutagenesis
results (for Pro-1, Arg-70, Arg-73, and Glu-114) invoke roles
for these residues in the dehalogenase activities of Cg10062.
These observations indicate that dehalogenation is active site-
dependent and not the consequence of a nonspeciﬁc encoun-
ter between Cg10062 and substrate.
Although Cg10062 is not an efﬁcient cis-CaaD or CaaD,
the rates of dehalogenation are still impressive in comparison
with the reported nonenzymatic rate (31). Horvat and
Wolfenden reported that the uncatalyzed rate is ∼2.2 × 10-12
s-1 at 25 °C( 31). Hence, Cg10062 shows an ∼1.6 × 1012-
fold rate enhancement using the cis isomer and a 9.0 × 108-
to 2.7 × 1010-fold rate enhancement using the trans isomer.
By comparison, cis-CaaD exhibits a 2.1 × 1012-fold rate
enhancement.
6 Like cis-CaaD, inactivation of Cg10062 is observed at higher
concentrations of 6 (>60 mM) (6, 8). This may be a function of the
enzyme’s slow processing of 6 coupled with presence of both neutral
and cationic Pro-1 at pH 9.2.
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(assuming Km reﬂects substrate binding) result from a more
spacious Cg10062 active site where larger side chain groups
found in cis-CaaD are replaced with smaller side chains in
Cg10062. As a result, the active site of Cg10062 could
accommodate both isomers, but they would bind with much
lower afﬁnity. An examination of the cis-CaaD crystal
structure shows that the active site pocket is deﬁned by Pro-
1, His-28, Thr-32, Thr-34, His-69, Arg-70, Arg-73, Tyr-103,
Met-112, and Glu-114 (9). As most of these same residues
are found in Cg10062, the active site is unlikely to be more
spacious.
There are, however, two intriguing exceptions. First, His-
69 in cis-CaaD is replaced with an isoleucine in Cg10062.
In cis-CaaD, His-28 and His-69 interact with the hydroxyl
group of Tyr-3. The signiﬁcance of this interaction is not
known, but one possibility is that it positions His-28 for the
interaction with the C-1 carboxylate group of the substrate.
The presence of the uncharged, hydrophobic isoleucine could
alter the position and/or modulate the properties of His-28
or otherwise change the properties of the active site.
The second, more striking exception involves an eight-
residue loop that connects the R-helix of a  -R-  motif to
the second  -strand. In cis-CaaD, Thr-32 and Thr-34 are part
of this loop that is made up of Leu-31, Thr-32, Gly-33, Thr-
34, Gln-35, His-36, Phe-37, and Leu-38. The same loop in
Cg10062 is signiﬁcantly different, consisting of Leu-31, Ala-
32, His-33, Ala-34, Pro-35, Lys-36, Tyr-37, and Leu-38. As
noted earlier, Thr-34 may be part of a pocket for the binding
of the 3-chloro group of the cis substrate. If the binding is
mediated by a hydrogen bond from Thr-34, this interaction
is no longer possible in Cg10062. Moreover, Gly-33 of cis-
CaaD is replaced with the bulky, charged His-33, and Gln-
35 (in cis-CaaD) is replaced with the rigid Pro-35. How these
changes affect the properties of the loop and whether this
loop plays a role in catalysis and/or speciﬁcity are not known.
Cystallographic and mutagenesis studies of Cg10062 serve
as the starting point for addressing these questions and are
being pursued.
Loops can frequently determine speciﬁcity, which has been
documented well in the enolase superfamily (32, 33). The
members of this superfamily are characterized by a ( /R)8
barrel (the so-called TIM barrel) and a capping domain (32).
The capping domain consists of two short loops. The active
sites of enolase superfamily members are located at the
interfaces of the two domains, where barrel residues function
as catalytic groups and loop residues confer speciﬁcity to
the individual members (33). A similar arrangement could
be operative in cis-CaaD with some modiﬁcations. One
possibility is that the catalytic groups are located in the core
 -R-  motif and additional determinants of speciﬁcity (and
perhaps catalysis) come from the loop residues. Moreover,
the position of the loop may exclude binding of the trans
isomer in cis-CaaD but allow it in Cg10062.
The sum of these observations suggests that Cg10062
could be a few mutations away from a highly speciﬁc and
efﬁcient cis-CaaD. Although Cg10062 is not necessarily the
progenitor for a cis-CaaD, it could be representative of one.
In one scenario, this progenitor, like Cg10062, has the core
catalytic machinery for a hydration reaction but lacks
speciﬁcity for the cis isomer. Mutations in the loop ac-
companied by the conversion of Ile-69 to a histidine might
provide the additional elements and complete the evolution
of Cg10062 to cis-CaaD. The consequences of these muta-
tions are currently being examined.
These results do not, however, give any hints about the
physiological role of Cg10062 in C. glutamicum. This strain
was isolated after the introduction of 1,3-dichloropropene
(1, Scheme 1) into the environment (34). However, BLAST
searches of the genome did not identify candidates for other
genes in the pathway, indicating that a catabolic pathway
for 1 is not likely present.
7 Nonetheless, the sequence and
functional properties suggest that Cg10062 is part of the
subfamily of  -R-  fold enzymes from which cis-CaaD
originated, and it could be representative of a progenitor.
This proposed relationship between Cg10062 and cis-CaaD
and the lack of an obvious genomic context for Cg10062
raise intriguing questions for a future investigation into the
biological function of Cg10062 in C. glutamicum. Mutational
and transcriptional analysis of the cg10062 gene to deﬁne
the conditions under which it is expressed would be one step
toward understanding the physiological relevance of Cg10062.
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